WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 2.9% of their position (5K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $5.5K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/13/2024ACC: 0001213900-24-052354
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+5K
Net shares
Net buyer
$5.5K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
5K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+562.00
Price / share
$1.08
Trade value
$606.96
% of position
0.3%
6/11/2024
175.43K→175.99K
Common Stock
Direct
Shares
+4.44K
Price / share
$1.11
Trade value
$4.93K
% of position
2.5%
6/12/2024
175.99K→180.43K
Total
Net shares
+5K
Net value
$5.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2024 | P · Purchase | +562.00 | $1.08 | $606.96 | 0.3% | 175.43K | 175.99K |
| Common Stock Direct | 6/12/2024 | P · Purchase | +4.44K | $1.11 | $4.93K | 2.5% | 175.99K | 180.43K |
| Total | +5K | $5.53K | ||||||
Derivative Transactions0
No derivative transactions reported